AS1411 Aptamer-Decorated Biodegradable Polyethylene Glycol-Poly(lactic-co-glycolic acid) Nanopolymersomes for the Targeted Delivery of Gemcitabine to Non-Small Cell Lung Cancer in Vitro

Journal of Pharmaceutical Sciences

Volumn 105, Issue 5, 2016, Pages 1741-1750

  Alibolandi, Mona ^a   Ramezani, Mohammad ^a   Abnous, Khalil ^a   Hadizadeh, Farzin ^b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

cancer chemotherapy; drug delivery system; encapsulation; nanoparticle; PLGA; polymeric drug delivery systems; targeted drug delivery

Indexed keywords

APTAMER; GEMCITABINE; NANOPARTICLE; NANOPOLYMERSOME; NUCLEOLIN; POLYGLACTIN; UNCLASSIFIED DRUG; AGRO 100; ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; MACROGOL DERIVATIVE; OLIGODEOXYRIBONUCLEOTIDE; POLYESTER; POLYETHYLENE GLYCOL-POLY(LACTIDE-CO-GLYCOLIDE); POLYMER;

A549 CELL LINE; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BIODEGRADATION; CELL PROLIFERATION; CELL TRANSPORT; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; COVALENT BOND; CYTOTOXICITY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; FEASIBILITY STUDY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE OVEREXPRESSION; HYDROPHILICITY; HYDROPHOBICITY; IN VITRO STUDY; INTERNALIZATION; MOLECULAR WEIGHT; MOLECULARLY TARGETED THERAPY; MTT ASSAY; NANOENCAPSULATION; NON SMALL CELL LUNG CANCER; PARTICLE SIZE; PROTEIN TARGETING; SURFACE PROPERTY; SUSTAINED DRUG RELEASE; ZETA POTENTIAL; A-549 CELL LINE; ANALOGS AND DERIVATIVES; ANIMAL; CHO CELL LINE; CRICETULUS; HAMSTER; HUMAN; LUNG TUMOR; METABOLISM; PROCEDURES; TUMOR CELL LINE;

A549 CELLS; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CHO CELLS; CRICETINAE; CRICETULUS; DEOXYCYTIDINE; DRUG DELIVERY SYSTEMS; HUMANS; LUNG NEOPLASMS; NANOPARTICLES; OLIGODEOXYRIBONUCLEOTIDES; POLYESTERS; POLYETHYLENE GLYCOLS; POLYMERS;

EID: 84964411259     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1016/j.xphs.2016.02.021     Document Type: Article

References (59)

1. American Lung Association. Trends in lung cancer morbidity and mortality, epidemiology and statistics unit: research and scientific affairs. Available at: http://www.lung.org/assets/documents/research/lc-trend-report.pdf/. Accessed March 14, 2016.
2. C.S. Dela Cruz, L.T. Tanoue, and R.A. Matthay Lung cancer: epidemiology, etiology, and prevention Clin Chest Med 32 2011 605 644
3. D.J. Stewart Lung cancer resistance to chemotherapy D.J. Stewart, Lung Cancer 2010 Humana Press, a part of Springer, Science+Business Media, LLC New York, NY 331 393
4. M. Shanker, D. Willcutts, J.A. Roth, and R. Ramesh Drug resistance in lung cancer Lung Cancer Targets Ther 1 2010 23 36
5. A. Sandler, and D.S. Ettinger Gemcitabine: single-agent and combination therapy in non-small cell lung cancer The Oncologist 4 3 1999 241 251
6. C. Manegold Gemcitabine (Gemzar) in non-small cell lung cancer Expert Rev Anticancer Ther 4 3 2004 345 360
7. J.K. Yan, H.L. Ma, X. Chen, J.J. Pei, Z.B. Wang, and J.Y. Wu Self-aggregated nanoparticles of carboxylic curdlan-deoxycholic acid conjugates as a carrier of doxorubicin Int J Biol Macromol 72C 2014 333 340
8. I. Levacheva, O. Samsonova, E. Tazina, and et al. Optimized thermosensitive liposomes for selective doxorubicin delivery: formulation development, quality analysis and bioactivity proof Colloids Surf B Biointerfaces 121 2014 248 256
9. C. Federico, V.M. Morittu, D. Britti, E. Trapasso, and D. Cosco Gemcitabine-loaded liposomes: rationale, potentialities and future perspectives Int J Nanomedicine 7 2012 5423 5436
10. Q. Zhou, L. Liu, D. Zhang, and X. Fan Preparation and characterization of gemcitabine liposome injections Pharmazie 67 10 2012 844 847
11. C. Celia, D. Cosco, D. Paolino, and M. Fresta Gemcitabine-loaded innovative nanocarriers vs GEMZAR: biodistribution, pharmacokinetic features and in vivo antitumor activity Expert Opin Drug Deliv 8 12 2011 1609 1629
12. D. Chitkara, A. Mittal, R.I. Mahato, and N. Kumar Core-shell nanoparticulate formulation of gemcitabine: lyophilization, stability studies, and in vivo evaluation Drug Deliv Transl Res 4 5-6 2014 439 451
13. C. Poon, C. He, D. Liu, K. Lu, and W. Lin Self-assembled nanoscale coordination polymers carrying oxaliplatin and gemcitabine for synergistic combination therapy of pancreatic cancer J Control Release 201 2015 90 99
14. S.S. Dhapare, and A.K. Dash Effect of differential drying techniques on PLGA nanoparticles containing hydrophobic and hydrophilic anticancer agents Ther Deliv 6 1 2015 27 39
15. S. Yalçin, M. Erkan, G. Ünsoy, M. Parsian, J. Kleeff, and U. Gündüz Effect of gemcitabine and retinoic acid loaded PAMAM dendrimer-coated magnetic nanoparticles on pancreatic cancer and stellate cell lines Biomed Pharmacother 68 6 2014 737 743
16. X. Zhao, F. Li, Y. Li, and et al. Co-delivery of HIF1α siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment of pancreatic cancer Biomaterials 46 2015 13 25
17. A.L. Papa, S. Basu, P. Sengupta, D. Banerjee, S. Sengupta, and R. Harfouche Mechanistic studies of gemcitabine-loaded nanoplatforms in resistant pancreatic cancer cells BMC Cancer 12 2012 419
18. N.S. Oltra, P. Nair, and D.E. Discher From stealthy polymersomes and filomicelles to "self" peptide-nanoparticles for cancer therapy Annu Rev Chem Biomol Eng 5 2014 281 299
19. C. Murdoch, K.J. Reeves, V. Hearnden, and et al. Internalization and biodistribution of polymersomes into oral squamous cell carcinoma cells in vitro and in vivo Nanomedicine (Lond) 5 7 2010 1025 1036
20. T. Anajafi, and S. Mallik Polymersome-based drug-delivery strategies for cancer therapeutics Ther Deliv 6 4 2015 521 534
21. R. Wang, R. Xiao, Z. Zeng, L. Xu, and J. Wang Application of poly(ethylene glycol)-distearoyl phosphatidylethanolamine (PEG-DSPE) block copolymers and their derivatives as nanomaterials in drug delivery Int J Nanomedicine 7 2012 4185 4198
22. M. Alibolandi, M. Ramezani, K. Abnous, and et al. In vitro and in vivo evaluation of therapy targeting epithelial-cell adhesion-molecule aptamers for non-small cell lung cancer J Control Release 209 2015 88 100
23. Y. Song, Z. Huang, Y. Song, and et al. The application of EDTA in drug delivery systems: doxorubicin liposomes loaded via NH4EDTA gradient Int J Nanomedicine 9 2014 3611 3621
24. G. Benedetto, C.G. Vestal, and C. Richardson Aptamer-functionalized nanoparticles as "smart bombs": the unrealized potential for personalized medicine and targeted cancer treatment Target Oncol 10 2015 467 485 2015 May 21
25. N.M. Danesh, P. Lavaee, M. Ramezani, K. Abnous, and S.M. Taghdisi Targeted and controlled release delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer-modified gold nanoparticles Int J Pharm 489 1-2 2015 311 317
26. Y. Tang, H. Hu, M.G. Zhang, and et al. An aptamer-targeting photoresponsive drug delivery system using "off-on" graphene oxide wrapped mesoporous silica nanoparticles Nanoscale 7 14 2015 6304 6310
27. F. Mongelard, and P. Bouvet AS-1411, a guanosine-rich oligonucleotide aptamer targeting nucleolin for the potential treatment of cancer, including acute myeloid leukemia Curr Opin Mol Ther 12 1 2010 107 114
28. E.M. Reyes-Reyes, F.R. Šalipur, M. Shams, M.K. Forsthoefel, and P.J. Bates Mechanistic studies of anticancer aptamer AS1411 reveal a novel role for nucleolin in regulating Rac1 activation Mol Oncol 9 7 2015 1392 1405
29. V. Dapić, P.J. Bates, J.O. Trent, and et al. Anti proliferative activity of G-quartet-forming oligonucleotides with backbone and sugar modifications Biochemistry 41 11 2002 3676 3685
30. J.Y. Xu, S. Lu, X.Y. Xu, and et al. Knocking down nucleolin expression enhances the radiosensitivity of non-small cell lung cancer by influencing DNA-PKcs activity Asian Pac J Cancer Prev 16 8 2015 3301 3306
31. H. Zhao, Y. Huang, C. Xue, and et al. Prognostic significance of the combined score of endothelial expression of nucleolin and CD31 in surgically resected non-small cell lung cancer PLoS One 8 2013 e54674
32. C.R. Ireson, and L.R. Kelland Discovery and development of anticancer aptamers Mol Cancer Ther 5 12 2006 2957 2962
33. M. Alibolandi, M. Ramezani, F. Sadeghi, K. Abnous, and F. Hadizadeh Epithelial cell adhesion molecule aptamer conjugated PEG-PLGA nanopolymersomes for targeted delivery of doxorubicin to human breast adenocarcinoma cell line in vitro Int J Pharm 479 1 2015 241 251
34. Grant GJ, Barenholz Y, Piskoun B, Bansinath M, Turndorf H, Bolotin EM. Liposomal bupivacaine compositions prepared using an ammonium sulfate gradient, U.S. patent, no. 6162462.
35. S. Hua Comparison of in vitro dialysis release methods of loperamide-encapsulated liposomal gel for topical drug delivery Int J Nanomedicine 9 2014 735 744
36. B.M. Discher, Y.Y. Won, D.S. Ege, and et al. Polymersomes: tough vesicles made from diblock copolymers Science 284 5417 1999 1143 1146
37. D.E. Discher, and A. Eisenberg Polymer vesicles Science 297 2002 967 973
38. F. Ahmed, and D.E. Discher Self-porating polymersomes of PEG-PLA and PEG-PCL: hydrolysis-triggered controlled release vesicles J Control Release 96 2004 37 53
39. T.O. Pangburn, K. Georgiou, F.S. Bates, and E. Kokkoli Targeted polymersome delivery of siRNA induces cell death of breast cancer cells dependent upon Orai3 protein expression Langmuir 28 35 2012 12816 12830
40. Y. Zhang, W. Zhang, A.H. Johnston, T.A. Newman, I. Pyykkö, and J. Zou Targeted delivery of Tet1 peptide functionalized polymersomes to the rat cochlear nerve Int J Nanomedicine 7 2012 1015 1022
41. L. Pourtau, H. Oliveira, J. Thevenot, and et al. Antibody-functionalized magnetic polymersomes: in vivo targeting and imaging of bone metastases using high resolution MRI Adv Healthc Mater 2 11 2013 1420 1424
42. C.W. Gan, S. Chien, and S.S. Feng Nanomedicine: enhancement of chemotherapeutical efficacy of docetaxel by using a biodegradable nanoparticle formulation Curr Pharm Des 16 21 2010 2308 2320
43. H. Maeda The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting Adv Enzyme Regul 41 2001 189 207
44. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J Control Release 65 2000 271 284
45. T. Casalini, F. Rossi, S. Lazzari, G. Perale, and M. Masi Mathematical modeling of PLGA microparticles: from polymer degradation to drug release Mol Pharm 11 11 2014 4036 4048
46. H.S. Yoo, and T.G. Park Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA-PEG block copolymer J Control Release 70 1-2 2001 63 70
47. Y. Fu, and W.J. Kao Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems Expert Opin Drug Deliv 7 4 2010 429 444
48. G. Haran, R. Cohen, L.K. Bar, and Y. Barenholz Transmembrane ammonium sulphate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases Biochim Biophys Acta 1151 1993 201 215
49. K. Shahani, and J. Panyam Highly loaded, sustained-343 release microparticles of curcumin for chemoprevention J Pharm Sci 100 7 2011 2599 2609
50. L. Tan, K.G. Neoh, E.T. Kang, W.S. Choe, and X. Su PEGylated anti-MUC1 aptamer-doxorubicin complex for targeted drug delivery to MCF7 breast cancer cells Macromol Biosci 11 10 2011 1331 1335
51. S.V. Lale, R.G. Aswathy, A. Aravind, D.S. Kumar, and V. Koul AS1411 aptamer and folic acid functionalized pH-responsive ATRP fabricated pPEGMA-PCL-pPEGMA polymeric nanoparticles for targeted drug delivery in cancer therapy Biomacromolecules 15 5 2014 1737 1752
52. J. Cheng, B.A. Teply, I. Sherifi, and et al. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery Biomaterials 28 5 2007 869 876
53. T.G. Iversen, T. Skotland, and K. Sandvig Endocytosis and intracellular transport of nanoparticles: present knowledge and need for future studies Nanotoday 6 2011 176 185
54. J. Zhang, X. Jia, X.J. Lv, Y.L. Deng, and H.Y. Xie Fluorescent quantum dot-labeled aptamer bioprobes specifically targeting mouse liver cancer cells Talanta 81 1-2 2010 505 509
55. X. Guo, L. Xiong, L. Yu, and et al. Increased level of nucleolin confers to aggressive tumor progression and poor prognosis in patients with hepatocellular carcinoma after hepatectomy Diagn Pathol 9 2014 175
56. Z.X. Liao, E.Y. Chuang, C.C. Lin, and et al. An AS1411 aptamer-conjugated liposomal system containing a bubble-generating agent for tumor-specific chemotherapy that overcomes multidrug resistance J Control Release 208 2015 42 51
57. Y. Zhong, F. Meng, C. Deng, and Z. Zhong Ligand-directed active tumor-targeting polymeric nanoparticles for cancer chemotherapy Biomacromolecules 15 6 2014 1955 1969
58. Z. Cao, R. Tong, A. Mishra, and et al. Reversible cell-specific drug delivery with aptamer-functionalized liposomes Angew Chem Int Ed Engl 48 2009 6494 6498
59. J. Guo, X. Gao, L. Su, and et al. Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery Biomaterials 32 2011 8010 8020